QA: EXICURE INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001698530_2023_EXICURE_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001698530, EXICURE INC.

  xvar xval
0 AssetsCurrent 10,051,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,530,000
3 remainder_Assets 10,747,000
4 LiabilitiesCurrent 1,639,000
5 LiabilitiesNoncurrent 6,767,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,890,000
9 ResearchAndDevelopmentExpense 19,767,000
10 remainder_Expenses 209,000
11 remainder_Revenues 28,826,000
12 remainder_NetIncome -542,000
13 remainder_ComprehensiveNetIncome 2,000
  yvar yval
0 Assets 23,328,000
1 Liabilities 8,406,000
2 Expenses 30,866,000
3 Revenues 28,826,000
4 StockholdersEquity 14,922,000
5 NetIncome -2,582,000
6 ComprehensiveNetIncome -2,581,000
7 BaseVar 45,985,000
8 EconomicCapitalRatio 1.45

Edgar->Model Mapping

Feature Distribution

Change over Time